Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study

Summary: Background: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of proven benefit and are recommended by guidelines for management of patients with heart failure and reduced ejection fr...

Full description

Bibliographic Details
Main Authors: Tiew-Hwa K Teng, PhD, Jasper Tromp, MD, Wan Ting Tay, MAppStat, Inder Anand, MD, Wouter Ouwerkerk, PhD, Vijay Chopra, MD, Gurpreet S Wander, DM, Jonathan JL Yap, MBBS, Michael R MacDonald, MBChB, Chang Fen Xu, MBBS, Yvonne MF Chia, MBBS, Wataru Shimizu, MD, A Mark Richards, MD, Adriaan Voors, MD, Carolyn SP Lam, MBBS
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X18303061